News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
656,184 Results
Type
Article (34604)
Company Profile (640)
Press Release (620940)
Multimedia
Podcasts (52)
Webinars (11)
Section
Business (198732)
Career Advice (2123)
Deals (36584)
Drug Delivery (103)
Drug Development (78305)
Employer Resources (164)
FDA (15379)
Job Trends (14687)
News (335263)
Policy (29265)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (1414)
Academic (1)
Accelerated approval (5)
Adcomms (14)
Allergies (81)
Alliances (47789)
ALS (93)
Alzheimer's disease (1305)
Antibody-drug conjugate (ADC) (126)
Approvals (15368)
Artificial intelligence (236)
Autoimmune disease (27)
Automation (12)
Bankruptcy (376)
Best Places to Work (10874)
BIOSECURE Act (22)
Biosimilars (98)
Biotechnology (437)
Bladder cancer (64)
Brain cancer (24)
Breast cancer (239)
Cancer (1974)
Cardiovascular disease (165)
Career advice (1753)
Career pathing (31)
CAR-T (143)
Cell therapy (412)
Cervical cancer (17)
Clinical research (64062)
Collaboration (809)
Compensation (513)
Complete response letters (27)
COVID-19 (2205)
CRISPR (40)
C-suite (242)
Cystic fibrosis (99)
Data (1987)
Decentralized trials (2)
Denatured (3)
Depression (49)
Diabetes (244)
Diagnostics (6309)
Digital health (18)
Diversity (3)
Diversity, equity & inclusion (37)
Drug discovery (112)
Drug pricing (98)
Drug shortages (24)
Duchenne muscular dystrophy (87)
Earnings (83274)
Editorial (37)
Employer branding (24)
Employer resources (140)
Events (109549)
Executive appointments (721)
FDA (16516)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (715)
Gene editing (106)
Generative AI (24)
Gene therapy (287)
GLP-1 (724)
Government (2944)
Grass and pollen (5)
Guidances (44)
Healthcare (15977)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (122)
Indications (27)
Infectious disease (2338)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (91)
Interviews (424)
IPO (17209)
IRA (41)
Job creations (4250)
Job search strategy (1459)
Kidney cancer (9)
Labor market (34)
Layoffs (532)
Leadership (17)
Legal (7380)
Liver cancer (68)
Lung cancer (281)
Lymphoma (126)
Machine learning (3)
Management (58)
Manufacturing (308)
MASH (62)
Medical device (13520)
Medtech (13525)
Mergers & acquisitions (19901)
Metabolic disorders (650)
Multiple sclerosis (78)
NASH (18)
Neurodegenerative disease (94)
Neuropsychiatric disorders (28)
Neuroscience (1834)
NextGen: Class of 2025 (5998)
Non-profit (1939)
Northern California (2554)
Now hiring (39)
Obesity (356)
Opinion (249)
Ovarian cancer (68)
Pain (85)
Pancreatic cancer (77)
Parkinson's disease (146)
Partnered (20)
Patents (229)
Patient recruitment (100)
Peanut (48)
People (56888)
Pharmaceutical (132)
Pharmacy benefit managers (16)
Phase I (20130)
Phase II (28564)
Phase III (21217)
Pipeline (1124)
Policy (130)
Postmarket research (1980)
Preclinical (8165)
Press Release (64)
Prostate cancer (94)
Psychedelics (35)
Radiopharmaceuticals (259)
Rare diseases (371)
Real estate (5815)
Recruiting (65)
Regulatory (20832)
Reports (35)
Research institute (1388)
Resumes & cover letters (330)
Rett syndrome (3)
RNA editing (4)
RSV (44)
Schizophrenia (73)
Series A (131)
Series B (87)
Service/supplier (26)
Sickle cell disease (52)
Southern California (2150)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (21)
Startups (3889)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (29)
The Weekly (48)
United States (22141)
Vaccines (636)
Venture capitalists (41)
Weight loss (241)
Women's health (24)
Worklife (18)
Date
Today (111)
Last 7 days (461)
Last 30 days (2332)
Last 365 days (33154)
2025 (9436)
2024 (35657)
2023 (40397)
2022 (50857)
2021 (54255)
2020 (51171)
2019 (42186)
2018 (32196)
2017 (32691)
2016 (31000)
2015 (36542)
2014 (29348)
2013 (24271)
2012 (25884)
2011 (26112)
2010 (23924)
Location
Africa (682)
Alabama (58)
Alaska (6)
Arizona (161)
Arkansas (11)
Asia (42342)
Australia (6778)
California (5885)
Canada (1934)
China (513)
Colorado (256)
Connecticut (271)
Delaware (130)
Europe (88829)
Florida (818)
Georgia (200)
Hawaii (1)
Idaho (55)
Illinois (441)
India (27)
Indiana (313)
Iowa (11)
Japan (149)
Kansas (99)
Kentucky (23)
Louisiana (10)
Maine (65)
Maryland (757)
Massachusetts (4564)
Michigan (229)
Minnesota (381)
Mississippi (2)
Missouri (78)
Montana (30)
Nebraska (22)
Nevada (55)
New Hampshire (65)
New Jersey (1688)
New Mexico (30)
New York (1650)
North Carolina (1036)
North Dakota (6)
Northern California (2554)
Ohio (180)
Oklahoma (10)
Oregon (39)
Pennsylvania (1281)
Puerto Rico (11)
Rhode Island (34)
South America (1076)
South Carolina (19)
South Dakota (1)
Southern California (2150)
Tennessee (80)
Texas (855)
Utah (173)
Virginia (136)
Washington D.C. (56)
Washington State (554)
West Virginia (3)
Wisconsin (48)
656,184 Results for "sumitomo chemical company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
December 2, 2024
·
6 min read
BioMidwest
Sumitomo Chemical and Valent BioSciences Announce Divestiture of Pace International and Future Collaboration with AgroFresh Solutions in the Postharvest Solutions Space
Sumitomo Chemical Co., Ltd. and Valent BioSciences LLC announced that Pace International LLC and its operations overseas will become part of AgroFresh Solutions, Inc., a well-established leader in the postharvest solutions space.
March 27, 2024
·
5 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
Business
Ginkgo Bioworks and Sumitomo Chemical Announce Expanded Partnership To Develop Functional Chemicals with Synthetic Biology
Sumitomo Chemical Co., Ltd and Ginkgo Bioworks today announced a new program to develop functional chemicals with synthetic biology and expand upon the companies’ existing biomanufacturing partnership.
July 18, 2023
·
6 min read
Genetown
Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials
Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene and its polymer, poly p-hydroxystyrene, using a combination of biosynthesis, chemosynthesis, and polymerization.
August 1, 2023
·
3 min read
Business
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and Sumitomo Mitsui Banking Corporation announced that the three companies signed a master agreement on April 22, 2024, to establish a joint venture company.
April 22, 2024
·
5 min read
Business
RevolKa Ltd.: Announcement of Milestone Achievement in the Collaborative Research with Sumitomo Pharma Co., Ltd.
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform is pleased to announce the successful completion of the collaborative drug discovery project with Sumitomo Pharma Co., Ltd. for rare diseases within the contractually agreed time frame.
June 23, 2023
·
3 min read
Deals
Sumitomo Pharma Subsidiary Companies in the U.S., Including Sumitomo Pharma Oncology, to Combine and Form Sumitomo Pharma America
Sumitomo Pharma Oncology, Inc., a wholly owned subsidiary of Sumitomo Pharma Co. Ltd, announced that it will combine with affiliate companies Sumitomo Pharma America Holdings, Inc., Sumitovant Biopharma Ltd., Myovant Sciences, Inc., Urovant Sciences, Inc., Enzyvant Therapeutics, Inc., and Sunovion Pharmaceuticals Inc. to form Sumitomo Pharma America, Inc. effective July 1, 2023.
April 3, 2023
·
11 min read
SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform signed a contract research agreement with SEKISUI CHEMICAL CO., LTD..
January 23, 2024
·
2 min read
Genetown
Sumitomo Pharma Presents New Clinical Data on DSP-5336 at the European Hematology Association 2024 Congress
Sumitomo Pharma America, Inc. (SMPA) today announced the oral presentation of data from the ongoing Phase 1/2 first-in-human study of DSP-5336 in patients with relapsed or refractory acute leukemia at the European Hematology Association (EHA) 2024 Hybrid Congress.
June 14, 2024
·
7 min read
1 of 65,619
Next
